Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

467
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
467
Liver Physiology01:30

Liver Physiology

429
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
429
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

83
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
83
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker screen-guided care for preterm birth risk in nulliparous pregnancies: a subgroup analysis of the PRIME randomized controlled trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same author

The association of maternal body mass index and cesarean delivery after preterm induction of labor.

American journal of obstetrics & gynecology MFM·2026
Same author

Hospital-Level Variation in Antenatal Corticosteroids for Late Preterm Births.

medRxiv : the preprint server for health sciences·2026
Same author

The Influence of Hindsight and Outcome Bias on Fetal Heart Rate Interpretation and Judgments of Obstetric Care Quality.

American journal of perinatology·2026
Same author

Selective Fetal Echocardiogram Referral Program for Pregnancies Affected by Pregestational Diabetes.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2026
Same author

Disparities in low dose aspirin use for preeclampsia risk reduction and opportunities for improvement.

Seminars in perinatology·2026

Related Experiment Video

Updated: Jun 5, 2025

Creation of Reversible Cholestatic Rat Model
09:39

Creation of Reversible Cholestatic Rat Model

Published on: May 21, 2011

15.0K

Simplifying Management of Cholestasis: A Proposal for a Classification System.

Minhazur Sarker1, Gladys A Ramos1, Lauren Ferrara2

  • 1Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, La Jolla, California.

American Journal of Perinatology
|December 4, 2024
PubMed
Summary

Intrahepatic cholestasis of pregnancy (ICP) stillbirth risk necessitates careful management. New data linking adverse outcomes to ICP severity are emerging, but clinical practice varies, highlighting the need for a standardized classification system.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.1K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.5K

Related Experiment Videos

Last Updated: Jun 5, 2025

Creation of Reversible Cholestatic Rat Model
09:39

Creation of Reversible Cholestatic Rat Model

Published on: May 21, 2011

15.0K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.1K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.5K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Hepatology

Background:

  • Intrahepatic cholestasis of pregnancy (ICP) is associated with a significant risk of stillbirth.
  • Current management often involves planned delivery around 36 weeks gestation to mitigate this risk.
  • Recent studies increasingly correlate adverse outcomes with ICP severity, yet clinical application of this knowledge is inconsistent.

Purpose of the Study:

  • To review current literature on ICP and associated adverse outcomes.
  • To propose a novel classification system for ICP based on severity.
  • To develop evidence-based algorithms for individualized ICP management.

Main Methods:

  • Review of recent retrospective studies and existing literature on ICP.
  • Development of a proposed ICP classification system.
  • Formulation of management algorithms linked to the proposed classification.

Main Results:

  • Multiple studies have refined the understanding of adverse outcomes linked to ICP.
  • Clinical adoption of severity-guided ICP management strategies is variable among healthcare providers.
  • A proposed classification system aims to standardize and simplify ICP management.

Conclusions:

  • A standardized ICP classification system is needed to guide clinical practice.
  • Individualized management based on ICP severity can optimize patient outcomes.
  • The proposed system and algorithms offer a framework for improved ICP care.